Ivacaftor
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1343 publications
Functional and biochemical characterization of Alyftrek® components reveals high-potency rescue of F508del-CFTR.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: August 19, 2026
Revision Endoscopic Sinus Surgery in Cystic Fibrosis With Chronic Rhinosinusitis: Before and After Cystic Fibrosis Transmembrane Conductance Regulator Triple Modulator Therapy.
Journal: American journal of rhinology & allergy
Published: August 03, 2026
Exploring the lived experiences of individuals with cystic fibrosis after the implementation of elexacaftor/tezacaftor/ivacaftor for treatment.
Journal: Therapeutic advances in respiratory disease
Published: July 25, 2026
Functional Proteomics and Biological Screening of Protein Misfolding Under ER Stress Conditions in a Neuroblastoma Cell Model.
Journal: Current issues in molecular biology
Published: July 07, 2026
Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a physiologically based pharmacokinetic (PBPK) modeling approach.
Journal: Expert opinion on drug metabolism & toxicology
Published: June 13, 2026
Microbial modulation of CFTR modulator exposure: In vitro interactions between elexacaftor-tezacaftor-ivacaftor and pulmonary and gut bacteria from people with cystic fibrosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 03, 2026
Cystic Fibrosis Mortality Trends 1999-2024-A CDC Wonder Study.
Journal: Advances in respiratory medicine
Published: May 27, 2026
Incorporation and properties of the tris-fluoromethylated motif into heterocycles, amino acids and analogues of elexacaftor and tezacaftor.
Journal: Chemical science
Published: May 20, 2026
Targeting von Willebrand factor selectively under inflammatory conditions.
Journal: bioRxiv : the preprint server for biology
Published: May 13, 2026
Identification of Der p1 inhibitors: Combining AI-based QSAR, molecular docking, molecular dynamics simulations and quantum physics.
Journal: Computational biology and chemistry
Published: May 11, 2026
CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
Journal: The Cochrane database of systematic reviews
Published: May 07, 2026
Functional Rescue of CFTR-Dependent Transport in a Pancreatic Ductal Epithelial Cell Model: The Impact of Pharmacological Modulation and Inflammation.
Journal: International journal of molecular sciences
Published: April 28, 2026
Last Updated: 09/19/2026